北京招聘

Identify and evaluate potential therapeutic targets through comprehensive literature study
Explore, evaluate and establish research platform to screen oncology/immunology targets, facilitate the discovery of therapeutic leads and define the mechanisms of action
Design and supervise master level scientists to execute in vitro experiments
Collaborate with colleagues from the broader scientific teams for data review, analysis and interpretation to evaluate the impact on research directions/goals
Engage colleagues in cross-disciplinary scientific discussion, present scientific data to internal and external audiences and keep abreast of relevant scientific literature
职位要求：
PhD with well-established track record of solid scientific background in academic or pharmaceutical setting, preferably in cancer biology, immunology or related field
Post-doctoral or biotech/pharma experience in developing and conducting laboratory research is a plus
In-depth knowledge and extensive hands-on experience in primary immune cell characterization and immune-assay development is a plus
Demonstrated ability to work independently and collaboratively with peers across multiple areas
Excellent analytical, organizational and trouble-shooting skills
Excellent scientific reporting and documentation proficiency
Excellent communication skills both in English and Chinese

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。